Results GLP-1RA reduced major cardiovascular events (MACE) by 14% (HR = 0.86, 95% CI 0.790.94, P = 0.006) with a non-significant heterogeneity between subgroups of patients with and without cardiovascular disease (P = 0.127)
pineal-derived short peptide Sequence: Glu-Asp-Arg (EDR) Formula / M.W.: CHNO, ~418.40 g/mol CAS: 175175-23-2 Compound 2: DSIP (Delta Sleep-Inducing Peptide) Class: Endogenous nonapeptide associated with delta-wave sleep induction Sequence: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu (WAGGDASGE) Formula / M.W.: CHNO, ~848.81 g/mol CAS: 62568-57-4 Compound 3: Selank Class: Synthetic heptapeptide anxiolytic
Random glucose GWAS in 493,036 individuals provides insights into diabetes pathophysiology, complications and treatment stratification
Two things happening at once, by design rather than accident
skin leakage was equivalent and pain scores were improved with the 4-mm needle
American College of Endocrinology position statement on the insulin resistance syndrome